UAB: Second Phase 3 Trial Confirms Dupilumab’s Effectiveness in Reducing Disease in …
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug — dupilumab — that showed rapid and …
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug — dupilumab — that showed rapid and …
